Failing to tackle antimicrobial resistance (AMR) would lead to cumulative world GDP losses between now and 2050 of between $2.1 and $124.5 trillion through labour supply disruption alone, not including other wider social and health costs.
With the rise of big data come complex problems, cultural and governance issues, and the need for policy frameworks. RAND Europe researchers connect diverse strands to help business, government, and citizens.
As noted in the latest RAND Review, modern medicine is built on the promise that antibiotics will clear away the bacteria that made everything from skin infections to surgery potentially lethal just a few generations ago. But drug-resistant strains of disease have spread in recent years.
The increase in the number of bacterial and viral infections that are resistant to antimicrobial drugs poses a growing global health threat: antimicrobial resistance (AMR). Recent economic modelling by RAND Europe has shed new light on the potential global impacts of failing to address the AMR threat.
If mental health problems are the most significant barrier preventing people on benefits from taking up employment, then why not transform how the system supports them? Policymakers could redirect some of the resources available to the benefit system towards improving mental health outcomes, and put more evidence-based interventions in place. The savings to the benefit system should logically pay for this investment.
RAND Europe announced today the appointment of two new members to its Council of Advisors: Sir Gregory Winter, master of Trinity College Cambridge, and László Andor, former European Union (EU) commissioner for employment, social affairs & inclusion.
RAND Europe's policy research focuses on eight specific areas. By establishing new angles of enquiry and, in some cases, new methodologies for research, we bring fresh approaches and add valuable contributions to traditional as well as new RAND research areas.